HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masutaka Furue Selected Research

Atopic Dermatitis (Atopic Eczema)

5/2021Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
4/2021Interleukin-31 and Pruritic Skin.
1/2021Inhibition of mite-induced dermatitis, pruritus, and nerve sprouting in mice by the endothelin receptor antagonist bosentan.
12/2020IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
12/2020Serum canine thymus and activation-regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis.
11/2020Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis.
9/2020Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.
9/2020Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis.
7/2020Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
7/2020IL-24: A new player in the pathogenesis of pro-inflammatory and allergic skin diseases.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masutaka Furue Research Topics

Disease

77Atopic Dermatitis (Atopic Eczema)
05/2021 - 11/2002
44Neoplasms (Cancer)
03/2022 - 05/2003
38Inflammation (Inflammations)
01/2022 - 03/2002
25Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 01/2002
25Melanoma (Melanoma, Malignant)
01/2021 - 05/2004
22Pruritus (Itching)
05/2021 - 02/2006
14Skin Diseases (Skin Disease)
02/2020 - 11/2007
10Extramammary Paget Disease (Paget Disease, Extramammary)
02/2021 - 01/2007
10Poisoning
01/2021 - 10/2008
9Dermatitis
03/2022 - 05/2010
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021 - 11/2007
9Yusho Disease
08/2015 - 04/2011
9Carcinogenesis
12/2013 - 01/2006
7Foodborne Diseases
01/2020 - 04/2007
7Hemangiosarcoma (Angiosarcoma)
01/2018 - 04/2005
6Eczema
05/2021 - 03/2011
6Bullous Pemphigoid (Pemphigoid)
05/2021 - 01/2009
6Neoplasm Metastasis (Metastasis)
08/2017 - 04/2009
6Infections
01/2008 - 02/2004
5Hypersensitivity (Allergy)
09/2020 - 02/2006
5Wounds and Injuries (Trauma)
12/2019 - 12/2011
5Skin Ulcer
12/2019 - 05/2004
5Wasting Syndrome (Wasting Disease)
05/2015 - 01/2012
4Benign Fibrous Histiocytoma (Dermatofibroma)
03/2022 - 05/2006
4Drug Eruptions (Drug Eruption)
07/2021 - 07/2004
4Chloracne
01/2021 - 07/2018
4Psoriatic Arthritis
08/2019 - 03/2012
4Pemphigus (Pemphigus Vulgaris)
01/2019 - 05/2007
4Phobic Disorders (Phobia)
02/2018 - 07/2011
4Necrosis
01/2018 - 08/2011
4Disease Progression
09/2017 - 03/2006
4Chronic Urticaria
04/2017 - 12/2010
4Asthma (Bronchial Asthma)
04/2015 - 09/2008
4Contact Dermatitis (Eczema, Contact)
05/2014 - 03/2002
3Prurigo
05/2021 - 05/2010
3Lichen Planus (Lichen Ruber Planus)
02/2021 - 10/2009
3Fever (Fevers)
02/2021 - 03/2008
3Cough
01/2021 - 10/2008
3Hyperpigmentation
01/2021 - 07/2008
3Exercise-Induced Allergies
10/2019 - 11/2011

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2003
24DioxinsIBA
01/2021 - 04/2007
18CytokinesIBA
01/2022 - 01/2002
14Immunoglobulin E (IgE)IBA
05/2021 - 04/2005
14Polychlorinated Biphenyls (PCBs)IBA
01/2021 - 04/2007
13Tacrolimus (Prograf)FDA LinkGeneric
05/2021 - 10/2003
13SteroidsIBA
01/2019 - 04/2003
12Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2020 - 01/2012
12Interleukin-17 (Interleukin 17)IBA
11/2020 - 03/2011
9Biological ProductsIBA
03/2022 - 07/2011
9InterleukinsIBA
01/2022 - 03/2011
9Interleukin-13IBA
11/2020 - 01/2003
9Pharmaceutical PreparationsIBA
08/2020 - 09/2005
8Filaggrin ProteinsIBA
03/2022 - 10/2014
8AutoantibodiesIBA
05/2021 - 05/2005
8Adrenal Cortex Hormones (Corticosteroids)IBA
05/2021 - 07/2004
8Chemokine CCL17IBA
05/2021 - 09/2007
7LigandsIBA
09/2020 - 05/2014
6ChemokinesIBA
01/2020 - 09/2007
6Polychlorinated Dibenzodioxins (TCDD)IBA
02/2018 - 01/2012
6Rice Bran OilIBA
02/2018 - 04/2007
5NivolumabIBA
05/2021 - 05/2017
5Interleukin-4 (Interleukin 4)IBA
07/2020 - 06/2019
5AntigensIBA
08/2019 - 09/2003
5Ointments (Pastes)IBA
12/2018 - 10/2003
5Polychlorinated DibenzofuransIBA
02/2018 - 04/2007
5AntibodiesIBA
08/2017 - 05/2007
5Prednisolone (Predate)FDA LinkGeneric
02/2012 - 04/2003
4nemolizumabIBA
04/2021 - 01/2017
4Immune Checkpoint InhibitorsIBA
02/2021 - 05/2017
4Endothelin-1 (Endothelin 1)IBA
01/2021 - 07/2011
4Histamine (Histamine Dihydrochloride)FDA Link
01/2021 - 06/2014
4Biomarkers (Surrogate Marker)IBA
12/2020 - 01/2019
4PeriostinIBA
09/2020 - 07/2012
4Interleukin-22 (IL-22)IBA
09/2020 - 01/2011
4methyl 4- (((3- (6,7- dimethoxy- 2- (methylamino)quinazolin- 4- yl)phenyl)amino)carbonyl)benzoateIBA
08/2019 - 07/2014
4Cytochrome P-450 CYP1A1 (CYP1A1)IBA
07/2018 - 01/2012
4Transcription Factors (Transcription Factor)IBA
01/2017 - 08/2008
4Interleukin-8 (Interleukin 8)IBA
11/2012 - 11/2003
4KalininIBA
11/2011 - 05/2005
4Cathepsin KIBA
01/2011 - 05/2010
4Interferon-gamma (Interferon, gamma)IBA
03/2008 - 01/2002
3tapinarofIBA
01/2022 - 10/2019
3Interleukin-33IBA
01/2022 - 03/2020
3Interleukin-23 (Interleukin 23)IBA
11/2021 - 07/2014
3dupilumabIBA
05/2021 - 06/2019
3Immunoglobulins (Immunoglobulin)IBA
05/2021 - 11/2016
3NectinsIBA
03/2021 - 08/2020
3Cell Adhesion MoleculesIBA
03/2021 - 08/2020
3LipidsIBA
02/2021 - 05/2007
3Interleukin-12 (IL 12)IBA
11/2020 - 05/2004
3InterferonsIBA
02/2020 - 01/2003
3EnzymesIBA
12/2019 - 04/2009
36-formylindolo(3,2-b)carbazoleIBA
02/2019 - 10/2017
3DesmogleinsIBA
01/2019 - 04/2009
3Dacarbazine (DIC)FDA LinkGeneric
01/2019 - 03/2005
3MucinsIBA
07/2018 - 01/2011

Therapy/Procedure

31Therapeutics
02/2021 - 01/2003
4Drug Therapy (Chemotherapy)
02/2021 - 01/2012
3Ligation
12/2019 - 01/2016